Reusable injection pens for GLP-1s: convenience or compliance risk?

What did @pepglowwithkate2 actually say?

Honestly? Not much that can be fact-checked. The transcript is song lyrics, not a medical explanation. The actual claims live in the caption: reusable injection pens offer "accuracy, comfort, and consistency" for what appears to be a tirzepatide or GLP-1 injection routine. The hashtags confirm this is GLP-1 territory. So we work with what the caption gives us.

The creator does add a disclaimer noting this reflects "personal preference" and is "intended for trained healthcare professionals or individuals with proper knowledge." That caveat matters. But 2,300 viewers are not all trained healthcare professionals, and TikTok does not filter audiences by clinical credential. The disclaimer does not neutralize the influence of watching someone use an off-label delivery device with apparent confidence.

Does the science back this up?

Reusable pens are legitimate medical devices, but their safety record depends heavily on the drug they were designed for. The short answer: using a reusable insulin pen for compounded tirzepatide or semaglutide is not the same as using it for insulin, and the evidence base for that specific application is thin.

Reusable injection pens were developed primarily for insulin delivery, and the literature on their accuracy is mostly insulin-focused. A 2020 review by Ignaut and Venekamp in Diabetes Technology and Therapeutics found that modern reusable pens deliver insulin with acceptable dose accuracy when used correctly. However, viscosity, concentration, and cartridge compatibility all affect accuracy, and compounded GLP-1 peptides are not standardized the way insulin cartridges are.

For FDA-approved GLP-1 devices like the Ozempic or Mounjaro pen, the delivery system is pre-engineered for that specific formulation. When users adapt reusable pen systems for compounded versions, they are operating outside validated device-drug combinations. The FDA has explicitly warned about compounded semaglutide and tirzepatide safety concerns, including dosing errors from non-standard delivery systems (FDA Drug Safety Communication, 2024).

What did they get wrong (or right)?

The creator gets partial credit for flagging technique, dosing, and sterile handling as important. Those three things are genuinely the most common failure points in self-injection, and naming them is not wrong. But calling reusable pens a source of "accuracy" without specifying device-drug compatibility is where this gets slippery.

Accuracy is not an inherent property of reusable pens. It is a property of a validated system used correctly. A reusable pen loaded with a compounded peptide in a non-manufacturer cartridge introduces variables that are not controlled. Dose dialing precision means nothing if the fill volume or concentration is off.

The bigger issue is what is missing. There is no mention of whether the pen was specifically designed for the peptide being used, no discussion of cartridge sourcing, and no acknowledgment that compounded GLP-1 products carry distinct handling requirements. Presenting this as a straightforward personal preference glosses over real complexity that matters for patient safety.

What should you actually know?

If you are using a GLP-1 medication, your delivery device should match the drug you are using. For FDA-approved tirzepatide or semaglutide, use the manufacturer-provided pen. Full stop. For compounded versions, your prescribing provider and compounding pharmacy should specify compatible delivery systems, and you should not adapt devices based on social media recommendations.

Sterile technique is non-negotiable. Needle reuse, improper cartridge storage, and contaminated injection sites are documented causes of infection and dosing failure. A 2019 study by Berard et al. in Diabetes Care found that pen needle reuse significantly increased the rate of lipohypertrophy, which in turn caused erratic drug absorption.

The disclaimer in this video does not transfer the responsibility of safe practice to the viewer. If you are not a trained healthcare professional, watching a preference video is not a substitute for device training from your provider. FormBlends-affiliated providers can walk you through proper injection technique as part of your treatment plan.